Anecdote wrote:
Also, as far as I am aware, Sriram has not yet had a trial involving metronidazole, probably because it would take too long for the university authorities. He does use it for individual people, though. They both se the need for clinical trials, but Lib, these are not so easy and inexpensive as you seem to assume. Also they tend to be only for rrms people and they have any other available treatments which they obviously will go for, so it isn't easy to find the required number of people.
Sarah
Sarah,
I greatly appreciate the efforts that Sriram, your husband and others are doing. I just wish others would do as much as they do. It is too bad that all the trials are focusing on RRMS and they are mising the point that there is an accumulated damage in the meantime.
If it helps others I am very happy to provide info on my "trial". As you know I had to stop CAP for a few months, but I want to continue it. I believe we must try everything to combat this disease. It might be a wishful thinking, but I thought that even without formal, expensive clinical trials if the treating doctors like Sriram collects data on patients (e.g. RRMS, SPMS, PPMS, active lesions are present or not, etc.) and see how abx works, then we might get closer to see what is going on. You remember, I told you earlier that neurologists I know do not rule out that bacteria is causing MS. It would be so great if somehing happened and there would be MS patients who would get abx under the supervision of neuros.
I also do not understand why MS patients have not tried FMT off-label. It is another, relatively quick option to do something against bad bacteria. What if abx works in another way what we assume with CPN.
I found this on the net:
"German researchers have linked gut bacteria to multiple sclerosis (click here). We all have millions of microbes living in our guts, normally to no ill effect. However, more and more research links these bacteria to some autoimmune diseases. The researchers who did this study used mice genetically engineered to develop a Multiple Sclerosis like disease, and allowed some to develop gut bacteria, and others to remain gut microbe free. About 80% of the mice with gut bacteria went on to develop MS like symptoms, while none of the sterile mice did. While it's a far cry to go from mice to humans, this study does demonstrate that intestinal microbes do interact with the immune system, something that has long been suspected. Of course, most of the bacteria are in our guts is harmless, and some even serve a beneficial effect, but these research results certainly warrant further investigation."